Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Loss of tumour-specific ATM protein expression is an independent prognostic factor in early resected NSCLC.

Petersen LF, Klimowicz AC, Otsuka S, Elegbede AA, Petrillo SK, Williamson T, Williamson CT, Konno M, Lees-Miller SP, Hao D, Morris D, Magliocco AM, Bebb DG.

Oncotarget. 2017 Mar 15. doi: 10.18632/oncotarget.16215. [Epub ahead of print]

2.

Expression of DNA damage response proteins in cervical cancer patients treated with radical chemoradiotherapy.

Ho CK, Kornaga EN, Klimowicz AC, Enwere EK, Dean M, Bebb GD, Phan T, Ghatage P, Magliocco AM, Lees-Miller SP, Doll CM.

Gynecol Oncol. 2017 Apr;145(1):176-184. doi: 10.1016/j.ygyno.2016.12.025. Epub 2017 Jan 26.

PMID:
28131528
3.

Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525.

Bell EH, Pugh SL, McElroy JP, Gilbert MR, Mehta M, Klimowicz AC, Magliocco A, Bredel M, Robe P, Grosu AL, Stupp R, Curran W Jr, Becker AP, Salavaggione AL, Barnholtz-Sloan JS, Aldape K, Blumenthal DT, Brown PD, Glass J, Souhami L, Lee RJ, Brachman D, Flickinger J, Won M, Chakravarti A.

JAMA Oncol. 2017 Jan 12. doi: 10.1001/jamaoncol.2016.6020. [Epub ahead of print]

PMID:
28097324
4.

Evaluation of three commercial progesterone receptor assays in a single tamoxifen-treated breast cancer cohort.

Kornaga EN, Klimowicz AC, Guggisberg N, Ogilvie T, Morris DG, Webster M, Magliocco AM.

Mod Pathol. 2016 Dec;29(12):1492-1500. doi: 10.1038/modpathol.2016.151. Epub 2016 Aug 26.

PMID:
27562489
5.

A systematic comparison of three commercial estrogen receptor assays in a single clinical outcome breast cancer cohort.

Kornaga EN, Klimowicz AC, Guggisberg N, Ogilvie T, Morris DG, Webster M, Magliocco AM.

Mod Pathol. 2016 Aug;29(8):799-809. doi: 10.1038/modpathol.2016.74. Epub 2016 Apr 29.

PMID:
27125355
6.

Fractal analysis of nuclear histology integrates tumor and stromal features into a single prognostic factor of the oral cancer microenvironment.

Bose P, Brockton NT, Guggisberg K, Nakoneshny SC, Kornaga E, Klimowicz AC, Tambasco M, Dort JC.

BMC Cancer. 2015 May 15;15:409. doi: 10.1186/s12885-015-1380-0.

7.

GLI1, CTNNB1 and NOTCH1 protein expression in a thymic epithelial malignancy tissue microarray.

Riess JW, West R, Dean M, Klimowicz AC, Neal JW, Hoang C, Wakelee HA.

Anticancer Res. 2015 Feb;35(2):669-76.

PMID:
25667444
8.

ATM, THMS, and RRM1 protein expression in nasopharyngeal carcinomas treated with curative intent.

Ko JJ, Klimowicz AC, Jagdis A, Phan T, Laskin J, Lau HY, Siever JE, Petrillo SK, Thomson TA, Rose MS, Bebb G, Magliocco AM, Hao D.

Head Neck. 2016 Apr;38 Suppl 1:E384-91. doi: 10.1002/hed.24004. Epub 2015 Jun 29.

PMID:
25640951
9.

Association of keratinization with 5-year disease-specific survival in oropharyngeal squamous cell carcinoma.

Cooper T, Biron VL, Adam B, Klimowicz AC, Puttagunta L, Seikaly H.

JAMA Otolaryngol Head Neck Surg. 2015 Mar;141(3):250-6. doi: 10.1001/jamaoto.2014.3335.

PMID:
25554966
10.

Evaluation of E-cadherin, β-catenin and vimentin protein expression using quantitative immunohistochemistry in nasopharyngeal carcinoma patients.

Hao D, Phan T, Jagdis A, Siever JE, Klimowicz AC, Laskin JJ, Thomson TA, Rose MS, Petrillo SK, Magliocco AM, Lau HY.

Clin Invest Med. 2014 Oct 4;37(5):E320-30.

PMID:
25282138
11.

The prognostic value of HPV status and p16 expression in patients with carcinoma of the anal canal.

Roldán Urgoiti GB, Gustafson K, Klimowicz AC, Petrillo SK, Magliocco AM, Doll CM.

PLoS One. 2014 Oct 1;9(10):e108790. doi: 10.1371/journal.pone.0108790. eCollection 2014.

12.

Tumor cell apoptosis mediated by cytoplasmic ING1 is associated with improved survival in oral squamous cell carcinoma patients.

Bose P, Thakur SS, Brockton NT, Klimowicz AC, Kornaga E, Nakoneshny SC, Riabowol KT, Dort JC.

Oncotarget. 2014 May 30;5(10):3210-9.

13.

Molecular predictors of locoregional and distant metastases in oropharyngeal squamous cell carcinoma.

Barber BR, Biron VL, Klimowicz AC, Puttagunta L, Côté DW, Seikaly H.

J Otolaryngol Head Neck Surg. 2013 Oct 16;42:53. doi: 10.1186/1916-0216-42-53.

14.

Prognostic utility of basaloid differentiation in oropharyngeal cancer.

Cooper T, Biron V, Adam B, Klimowicz AC, Puttagunta L, Seikaly H.

J Otolaryngol Head Neck Surg. 2013 Dec 19;42:57. doi: 10.1186/1916-0216-42-57.

15.

The prognostic impact of a combined carbonic anhydrase IX and Ki67 signature in oral squamous cell carcinoma.

Klimowicz AC, Bose P, Petrillo SK, Magliocco AM, Dort JC, Brockton NT.

Br J Cancer. 2013 Oct 1;109(7):1859-66. doi: 10.1038/bjc.2013.533. Epub 2013 Sep 5.

16.

Bladder preservation therapy for muscle-invading bladder cancers on Radiation Therapy Oncology Group trials 8802, 8903, 9506, and 9706: vascular endothelial growth factor B overexpression predicts for increased distant metastasis and shorter survival.

Lautenschlaeger T, George A, Klimowicz AC, Efstathiou JA, Wu CL, Sandler H, Shipley WU, Tester WJ, Hagan MP, Magliocco AM, Chakravarti A.

Oncologist. 2013 Jun;18(6):685-6. doi: 10.1634/theoncologist.2012-0461. Epub 2013 May 31.

17.

Assessment of ERCC1 and XPF protein expression using quantitative immunohistochemistry in nasopharyngeal carcinoma patients undergoing curative intent treatment.

Jagdis A, Phan T, Klimowicz AC, Laskin JJ, Lau HY, Petrillo SK, Siever JE, Thomson TA, Magliocco AM, Hao D.

Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1340-5. doi: 10.1016/j.ijrobp.2012.09.032. Epub 2012 Nov 22.

PMID:
23182703
18.

Quantification of ER/PR expression in ovarian low-grade serous carcinoma.

Escobar J, Klimowicz AC, Dean M, Chu P, Nation JG, Nelson GS, Ghatage P, Kalloger SE, Köbel M.

Gynecol Oncol. 2013 Feb;128(2):371-6. doi: 10.1016/j.ygyno.2012.10.013. Epub 2012 Oct 24.

PMID:
23103384
19.

Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes.

Peck AR, Witkiewicz AK, Liu C, Klimowicz AC, Stringer GA, Pequignot E, Freydin B, Yang N, Ertel A, Tran TH, Girondo MA, Rosenberg AL, Hooke JA, Kovatich AJ, Shriver CD, Rimm DL, Magliocco AM, Hyslop T, Rui H.

Breast Cancer Res. 2012 Oct 4;14(5):R130. doi: 10.1186/bcr3328.

20.

Basal Ki67 expression measured by digital image analysis is optimal for prognostication in oral squamous cell carcinoma.

Klimowicz AC, Bose P, Nakoneshny SC, Dean M, Huang L, Chandarana S, Magliocco AM, Wayne Matthews T, Brockton NT, Dort JC.

Eur J Cancer. 2012 Sep;48(14):2166-74. doi: 10.1016/j.ejca.2012.04.010. Epub 2012 Aug 12.

PMID:
22892062

Supplemental Content

Loading ...
Support Center